Adherence to recommended clinical guidelines in extensive disease small-cell lung cancer across the US, Europe, and Japan

Overview of attention for article published in Therapeutics and Clinical Risk Management, February 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 18 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 19 publications that cite this research output.

19

The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.

Small cell lung carcinoma with KIF5B-RET fusion partially responded to the 4th-line therapy with anlotinib: A case report

Article in World Journal of Clinical Cases (August 2024)

Identifying drug candidates for pancreatic ductal adenocarcinoma based on integrative multiomics analysis

Article in Journal of Gastrointestinal Oncology (June 2024)

Efficacy and safety of anti-PD-1 inhibitor versus anti-PD-L1 inhibitor in first-line treatment of extensive-stage small cell lung cancer: a multicenter retrospective study

Article in BMC Cancer (January 2024)